Lisdexamfetamine (Vyvanse) prior authorization at Priority Health
Submission criteria, P2P prep, and appeal path if denied — for prescribers and PA staff
Priority Health requires prior-authorization documentation for Lisdexamfetamine (Vyvanse): a diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. Standard PA decisions return on the clock printed in the current member-specific payer source; if denied, use the appeal window printed on the denial notice to appeal.
The PA criteria you'll need to meet
Priority Health reviews Lisdexamfetamine (Vyvanse) prior authorizations against its medical policy . Priority Health-specific context: Subsidiary of Corewell Health (Michigan integrated health system, formed from Beaumont + Spectrum 2022); ~1.3M members. Second-largest insurer in Michigan after BCBS Michigan. Michigan DIFS oversight.
Documentation packet checklist
- Chart note with diagnosis (ICD-10 code) and clinical severity markers
- Documented failure of, contraindication to, or intolerance of step-therapy alternatives in this class
- Prior treatment history including dosing, duration, and reason for discontinuation
- Relevant labs, imaging, or assessment scores supporting medical necessity
- Prescriber attestation linking the FDA-approved indication to the patient's presentation
- Priority Health's medical policy URL referenced in the cover letter
Denial scenarios to check against the current policy
These are preparation scenarios, not frequency claims. Use only those supported by the current member-specific source:
- West Michigan narrow-network restrictions
- Step therapy on specialty drugs
- Medicare Advantage Part B drug step therapy
- Behavioral health network adequacy
Lisdexamfetamine (Vyvanse)-specific review scenarios and context
Check whether the current notice cites any of these label-, REMS-, or policy-related scenarios:
- Step therapy requiring amphetamine first
- Non-formulary
- Quantity limit
Brand: Vyvanse. Generic available since 2023.
Manufacturer patient-assistance program: Takeda Help at Hand — relevant when a Priority Health denial sticks and the patient needs bridge access while appealing.
How Priority Health approaches Stimulants for ADHD PAs
For Lisdexamfetamine, check whether the current Priority Health Stimulants for ADHD policy cites behavioral health network adequacy. Pharmacy-benefit review for Lisdexamfetamine at Priority Health is routed through Express Scripts. The applicable review clock depends on the member's current product, whether the request is complete and urgent, and governing plan rules. Confirm receipt and timing with Priority Health; if denied, use the filing date and route printed on that denial notice. Priority Health's controlled-substance overrides require prescriber attestation of DSM-5 ADHD diagnosis and a quantity rationale within the FDA-labeled daily maximum. Priority Health is domiciled in MI, so unresolved appeals escalate to the MI insurance department's external-review program for fully-insured policies (self-funded ERISA plans route to the DOL EBSA instead).
If the PA is denied
Verify the appeal window and decision clock in the current denial notice and member-specific payer source before relying on either. Submit through the provider portal (https://www.priorityhealth.com/provider) with the same packet plus an applicable, current clinical source supporting Lisdexamfetamine (Vyvanse)for the patient's indication.
Helping a patient appeal the denial directly? See the consumer guide: How to appeal a Priority Health denial on DenialHelp.
Contact Priority Health
- Provider portal: https://www.priorityhealth.com/provider
Frequently asked questions
What documentation does Priority Health need for Lisdexamfetamine (Vyvanse) prior auth?
Priority Health's typical PA packet for Lisdexamfetamine (Vyvanse): (1) chart note documenting the indication and prior-treatment failures, (2) supporting lab/imaging where indicated, (3) prescriber attestation that step-therapy alternatives were tried or contraindicated, (4) FDA-approved indication mapped to ICD-10 diagnosis.
What's the turnaround time at Priority Health?
Verify the decision clock in the current member-specific payer policy and request receipt. Product type, urgency, state law, and plan terms can change the applicable timing; this page does not supply an operational deadline.
What documentation issues should be checked for Lisdexamfetamine (Vyvanse) at Priority Health?
Preparation scenarios to check against the current notice and policy include: West Michigan narrow-network restrictions; Step therapy on specialty drugs; Medicare Advantage Part B drug step therapy. These are not measured frequency claims. For Lisdexamfetamine (Vyvanse), verify whether the actual denial raises step therapy, indication, or another plan-specific criterion before responding.
Why does Priority Health impose quantity limits on Lisdexamfetamine?
Controlled-substance quantity limits at Priority Health typically track DEA Schedule II daily maximum dispensing rules and the FDA-labeled maximum daily dose for the formulation. Appeal a quantity limit by attaching prescriber attestation of the calculated daily dose, the formulation rationale (IR vs ER), and the DSM-5 diagnosis documentation. Federal law does not prohibit ADHD stimulant quantity limits — these are appealed on medical-necessity grounds, not parity grounds. Pharmacy-benefit handling is routed through Express Scripts. External-review escalation for Priority Health fully-insured policies sits with the MI insurance department.
How do I prep for a peer-to-peer with Priority Health on Lisdexamfetamine (Vyvanse)?
Lead with the FDA-approved indication and the specific clinical criteria the policy lists. Have the patient's chart open, document number, and policy URL on screen. State your name and credentials, the policy number, the indication, and the documented failures of step-therapy alternatives. Keep notes — if the P2P reviewer overturns, get the decision in writing.
Related PA criteria
Generate the Lisdexamfetamine (Vyvanse) PA packet
Open ApprovalHelp — generate a Lisdexamfetamine (Vyvanse) prior-auth packet tailored to Priority Health's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com